Drugs / Collagen
Trials 5 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 02 trials | ||||||
| Phase 0 | NCT05479877 | Sep 2022 → Sep 2023 | exposure, dental pulp | Cairo University | Unknown | No outcome recorded |
| Phase 0 | NCT03323567 | Jan 2016 → Oct 2017 | temporomandibular joint disorder | Medical University of Silesia | Completed | No outcome recorded |
| Phase 42 trials | ||||||
| Phase 4 | NCT04492748 | Jul 2020 → Sep 2021 | rotator cuff syndrome, tendinosis | Sutherland Medical Center | Unknown | No outcome recorded |
| Phase 4 | NCT02507661 | Jun 2015 → Jan 2018 | — | University of Belgrade | Completed | No outcome recorded |
| Phase not applicable1 trial | ||||||
| — | NCT04112888 | May 2017 → Apr 2018 | pelvis syndrome | Althaia Xarxa Assistencial Universitària de Manresa | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 5 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | collagen | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02507661 ↗ |
| Modality | Protein / enzyme biologic | “Collagen, a protein that's present abundantly in humans” NCT05479877 ↗ |
| Route | Intramuscular | “intramusclular injections of MD Muscle collagen” NCT03323567 ↗ |